What AFib Does to the Heart
Atrial fibrillation is a chaotic electrical rhythm originating in the upper chambers (atria) of the heart. Instead of contracting in a coordinated way, the atria quiver rapidly and irregularly — sometimes 300–600 times per minute — while the ventricles respond erratically to produce an irregular heartbeat.
The most serious consequence of AFib is stroke. When the atria fibrillate instead of contracting properly, blood pools in a small pouch of the left atrium called the left atrial appendage. Pooled blood clots. Those clots can then travel to the brain. AFib is responsible for approximately 20–25% of all ischemic strokes, and AFib-related strokes tend to be larger and more disabling than strokes from other causes.
AFib also stresses the heart over time. Rapid, irregular rates can weaken the heart muscle — a condition called tachycardia-induced cardiomyopathy. Even patients who feel they've "adjusted" to their AFib can be experiencing progressive but silent heart muscle damage.
What an Echocardiogram Shows in AFib Patients
An echocardiogram in the context of AFib evaluation answers several critical questions. First, it assesses left atrial size. An enlarged left atrium is both a consequence of AFib and a predictor of recurrence — patients with larger atria are less likely to maintain normal sinus rhythm after cardioversion and more likely to progress from paroxysmal (intermittent) to persistent AFib.
Second, it evaluates left ventricular function and ejection fraction. If the heart muscle has been weakened by rapid rates, the echo will show reduced function — which changes the treatment strategy significantly. Some patients in rate-controlled AFib who feel fine have ejection fractions in the 30s.
Third, the echo assesses valvular disease. Mitral valve disease — particularly mitral stenosis and mitral regurgitation — is closely associated with AFib. In fact, AFib in a young person without obvious risk factors should prompt careful evaluation for underlying valvular pathology.
Stroke Risk Assessment and Anticoagulation
The decision about whether to start blood thinners (anticoagulants) in AFib patients is guided by a risk score called CHA₂DS₂-VASc, which accounts for age, sex, history of heart failure, hypertension, stroke, diabetes, and vascular disease. The echocardiogram contributes directly to this score — it can confirm or rule out heart failure and provide evidence of structural heart disease.
Echocardiographic findings can also change the choice of anticoagulant. Patients with AFib related to moderate or severe mitral stenosis, or AFib with a mechanical heart valve, require warfarin rather than the newer direct oral anticoagulants. This distinction is only possible with echocardiographic imaging.
Monitoring Over Time
For patients with AFib, an echocardiogram isn't a one-time test — it's part of ongoing surveillance. Changes in atrial size, ventricular function, or valve status can indicate disease progression that warrants a change in management. Annual or biannual echocardiograms are commonly recommended for AFib patients on rate or rhythm control therapy.
Access to timely echocardiography has historically been a challenge — cardiology wait times in many parts of Maine can stretch to weeks or months. BlackPoint Diagnostics provides cardiologist-reviewed echocardiograms at your home, typically within days of scheduling, with results in 24–48 hours.
